424B5SYRECIK 0001636282

Spyre Therapeutics, Inc.

Name: SEC EDGAR filing 0001628280-26-064924
Creator: Spyre Therapeutics, Inc.
License: https://www.usa.gov/government-works

Prospectus supplement (424B5) filed October 5, 2026.

Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.

Open the filing on SEC.gov

Filing facts

Accession number: 0001628280-26-064924
Filer: Spyre Therapeutics, Inc.
Ticker: SYRE
CIK: 0001636282
Form type: 424B5
Form description: Prospectus supplement
Filed at: October 5, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 5, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1636282/000162828026064924/0001628280-26-064924-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Spyre Therapeutics, Inc. (0001636282) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001628280-26-064924.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.